Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Autacoids And Related Drug Market Size from 2025 to 2034?
The market for autacoids and related drugs has experienced robust growth in recent times. The market size, which is expected to grow from $50.15 billion in 2024 to $52.81 billion in 2025, is set for a compound annual growth rate (CAGR) of 5.3%. The notable expansion during the historical period can be credited to the rising instances of inflammatory diseases, increased utilization of prostaglandins in obstetrics, an upsurge in prescribed antihistamines, the expanded use of serotonin agonists, and the intensifying need for medications to alleviate migraines.
Predictions show robust surge in the autacoids and related drug market in the following years, expanding to a worth of $66.2 billion by 2029 with a compound annual growth rate (CAGR) of 5.8%. This prospective upswing during the forecast interval is linked to factors such as an increase in the elderly population, escalating incidences of chronic respiratory conditions, uptake of personalized medicines, wider healthcare reach in developing economies, and a growing number of cardiovascular disorders. The forecast period will be characterized by key trends such as the inclusion of artificial intelligence in drug development, production of dual-action autacoid medicines, use of biosimilars in autacoid remedies, expansion in self-medication and over-the-counter products, along with the application of nanotechnology in drug composition.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp
What Are the Core Growth Drivers Propelling the Autacoids And Related Drug Market Forward?
The escalating occurrence of heart-related diseases is predicted to fuel the expansion of the autacoids and associated drugs market. The term ‘cardiovascular diseases’ encompasses a collection of ailments that impact the heart and blood vessels, such as coronary artery disease, heart failure, stroke, and hypertension. The rise in these illnesses is mainly due to unhealthy food habits. Consuming excessive amounts of saturated fats, trans fats, added sugars, and sodium can lead to issues such as high blood pressure, obesity, and increased cholesterol levels, significantly increasing the risk for heart diseases. Autacoids and their related drugs improve heart health by managing vascular tone and inflammation, vital for conditions like heart failure and hypertension. These drugs act by targeting pathways associated with nitric oxide, endothelin, and prostacyclin to enhance endothelial function, encourage vasodilation, and decrease vascular resistance. For instance, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported an increase in deaths caused by coronary heart disease (CHD), rising from 14,100 in 2021 to 14,900 in 2022. Hence, the escalating occurrence of cardiovascular diseases is encouraging the growth of the autacoids and related drugs market.
What Segment Types Define the Autacoids And Related Drug Market Structure?
The autacoids and related drug market covered in this report is segmented –
1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin
2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation
3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders
4) By End User: Hospitals, Clinics, Homecare, Pharmacies
Subsegments:
1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists
2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2α (PGF2α) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs
3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors
4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators
5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24159&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Autacoids And Related Drug Market?
North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theAutacoids And Related Drug Industry Evolution?
Firms leading the market in autacoids and associated drugs are striving to produce innovative products, including antihistamines, that enhance treatment effectiveness, minimize side effects and address evolving allergic and inflammatory conditions with a higher level of safety and accuracy. Antihistamines are drugs that neutralize the impact of histamine, a compound produced by the immune system during an allergic response. For example, in March 2023, Bilastine was launched as an over-the-counter medicine by Tiefenbacher Pharmaceuticals, a pharmaceutical company based in Germany. This is a major progress in making effective allergy therapies more accessible. The 20 mg Bilastine tablets provide a second-generation, non-sedating antihistamine option for patients dealing with allergic reactions like hay fever and urticaria.
View the full report here:
https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report
What Is the Definition of the Autacoids And Related Drug Market?
Autacoids and related drugs are biologically active substances produced by the body that act locally to regulate physiological functions, typically within a specific tissue or organ. They are involved in inflammation, smooth muscle contraction, immune responses, and blood flow regulation. Autacoids exert their effects by binding specific receptors on target cells, initiating signaling pathways that influence cellular activity.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24159
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
